
2022
Blood Scheme
A blood test company raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak. You are the only journalist who found out this is a scam. Publish your article before the company is listed!
IndieStrategy
Screenshots
Reviews
Nobody has published a review of this game yet.
Your save
Where to play
There’s no “game over” here.
© 2026 GitThreeLab · Game data: IGDB.com












